Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices
Abstract Background Myelosuppression is a major dose‐limiting complication of chemotherapy for patients with extensive‐stage small cell lung cancer (ES‐SCLC). The objective was to describe the burden of myelosuppression, treatment patterns, and supportive care use among patients with ES‐SCLC treated...
Main Authors: | Lowell Hart, Augustina Ogbonnaya, Kristen Boykin, Kathryn Deyoung, Ray Bailey, Trevor Heritage, Lorena Lopez‐Gonzalez, Huan Huang, Lucio Gordan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5738 |
Similar Items
-
Promotion of myelopoiesis in myelosuppressed mice by Ganoderma lucidum polysaccharides
by: Xiao Ling Zhu, et al.
Published: (2012-02-01) -
H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets
by: Huan-Di Liu, et al.
Published: (2016-02-01) -
Effect of an Ayurveda antidote Dooshivishari Agada in carboplatin induced myelosuppression in Male Wistar rats
by: Santosh F. Patil, et al.
Published: (2022-07-01) -
The Impact of the Epigenetic Cancer Drug Azacitidine on Host Immunity: The Role of Myelosuppression, Iron Overload and <i>tp53</i> Mutations in a Zebrafish Model
by: Shu-Ching Wang, et al.
Published: (2019-09-01) -
Evaluation of The Effect of Fisetin against Cyclophosphamide-Induced Myelosuppression and Oxidative Stress in Male Albino Rats
by: Amani Jabbar, et al.
Published: (2023-09-01)